Oxford, UK and Delhi; 18 April 2024: In a significant stride towards addressing the challenge of Men-B disease, Serum Institute of India Pvt. Ltd (SIIPL) and the University of Oxford have formalised a Licence of Technology Agreement negotiated by Oxford University Innova......
View Details

Related News

• NOC solely for Export purpose from Zonal Offices through online mode from May 15 (01-05-2024)

---

• Confessional Statements u/s 67 NDPS Act are not admissible in Evidence: SC (01-05-2024)

---

• FTC targeting more than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs (01-05-2024)

---

• Hyderabad police bust illegal sale of counterfeit Oxytocin injections in Hyderabad, apprehends three (01-05-2024)

---

• DCA officials seize Ayurvedic medicines over misleading claims (01-05-2024)

---

• SC exempts Ramdev from personal appearance for next hearing in misleading ads case (30-04-2024)

---

• Tripura: Four Bihar youth held with banned cough syrup worth Rs 1.72 lakh (30-04-2024)

---

• Sugar content in Cerelac lower than FSSAI limit: Nestle (30-04-2024)

---

• US FDA approves First Drug Indicated in Patients with WHIM Syndrome (30-04-2024)

---

• Four-fold rise in immunodeficiency cases in seven years (30-04-2024)

---